PH vs PLRX · P/E 28, rev $19.85B vs $77.3M cap
Parker-Hannifin Corporation (PH) versus Pliant Therapeutics Inc (PLRX) — a side-by-side from cached financials, not a winner call.
Parker-Hannifin Corporation (PH) is a specialty industrial machinery company listed on US.
Pliant Therapeutics Inc (PLRX) is a biotechnology company listed on US.
Latest reported PH revenue for 2025-06-30 was $19.85B. Net income was $3.53B. PH currently screens at market cap $91.89B and trailing P/E 27.7.
Latest reported PLRX revenue for 2024-12-31 was $0. Net income was -$210.3M. Revenue was down 100.0% from 2023-12-31 to 2024-12-31. PLRX currently screens at market cap $77.3M.
PH currently screens at market cap $91.89B and trailing P/E 27.7. PLRX currently screens at market cap $77.3M.
Not investment advice. Open the PH and PLRX stock pages for the full models.
Not investment advice.